Induction gemcitabine and stereotactic body radiotherapy for locally advanced nonmetastatic pancreas cancer.
暂无分享,去创建一个
Tara Kent | Anand Mahadevan | R. Sullivan | A. Bullock | T. Kent | D. Pleskow | M. Callery | A. Mahadevan | C. Vollmer | R. Miksad | E. Buchbinder | Ryan Sullivan | Michael Goldstein | M. Sawhney | Douglas Pleskow | Andrea Bullock | Rebecca Miksad | Mandeep Sawhney | Elizabeth Buchbinder | Charles Vollmer | Mark Callery | M. Goldstein
[1] Christopher G Willett,et al. Locally advanced pancreatic cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] P. Massucco,et al. Phase II Trial of Primary Radiation Therapy and Concurrent Chemotherapy for Patients with Locally Advanced Pancreatic Cancer , 2005, Oncology.
[3] A. Benson,et al. A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201 , 2008 .
[4] H. Keen,et al. ORAL HYPOGLYCÆMICS IN DIABETES MELLITUS , 1975, The Lancet.
[5] K. Griffith,et al. Phase I radiation dose-escalation trial of intensity-modulated radiotherapy (IMRT) with concurrent fixed dose-rate gemcitabine (FDR-G) for unresectable pancreatic cancer. , 2009, Journal of Clinical Oncology.
[6] H. von der Maase,et al. Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[7] J. Berlin,et al. Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-dose-rate infusion [FDR]) versus gemcitabine + oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201). , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] E. Touboul,et al. Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J. Cameron,et al. NCCN practice guidelines for pancreatic cancer. , 1997, Oncology.
[10] B. Chauffert,et al. Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of the 2000-01 FFCD/SFRO study. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[11] B. Erickson,et al. Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12 , 2004, American journal of clinical oncology.
[12] J. Roeske,et al. Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: toxicity and clinical outcome. , 2004, International journal of radiation oncology, biology, physics.
[13] A Multi‐Institutional Comparative Trial of Radiation Therapy Alone and in Combination with 5‐fluorouracil for Locally Unresectable Pancreatic Carcinoma , 1979, Annals of surgery.
[14] G. Schwartz,et al. A phase I study of erlotinib in combination with gemcitabine and radiation in locally advanced, non-operable pancreatic adenocarcinoma. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.
[15] Douglas B. Evans,et al. Induction chemotherapy selects patients with locally advanced, unresectable pancreatic cancer for optimal benefit from consolidative chemoradiation therapy , 2007, Cancer.
[16] J. Barkin,et al. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5‐fluorouracil), and high dose radiation + 5‐fluorouracil. The gastrointestinal tumor study group , 1981, Cancer.
[17] P. Engstrom,et al. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] D. Pleskow,et al. Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. , 2010, International journal of radiation oncology, biology, physics.
[19] Albert C Koong,et al. Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. , 2004, International journal of radiation oncology, biology, physics.
[20] R. Schilsky,et al. A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo (P) in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB , 2007 .
[21] J. Tepper,et al. Cancer and leukemia group B (CALGB) 89805 , 2003 .
[22] Bond-Smith Giles,et al. Only women with symptoms need to have their breast implants removed, says government , 2012 .
[23] Daniel T Chang,et al. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas , 2009, Cancer.
[24] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[25] Dwight E Heron,et al. Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas , 2011, American journal of clinical oncology.
[26] A. Ko,et al. Radiation therapy in operable and locally advanced pancreatic cancer. , 2010, Journal of the National Comprehensive Cancer Network : JNCCN.
[27] D. Winchester,et al. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. , 1999, Journal of the American College of Surgeons.
[28] W. Curran,et al. Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] N. Neerchal,et al. Image-Guided Stereotactic Radiosurgery for Locally Advanced Pancreatic Adenocarcinoma Results of First 85 Patients , 2010, Journal of Gastrointestinal Surgery.
[30] L. Case,et al. Phase II Trial of Induction Gemcitabine/CPT-11 Followed by a Twice-Weekly Infusion of Gemcitabine and Concurrent External Beam Radiation for the Treatment of Locally Advanced Pancreatic Cancer , 2005, American journal of clinical oncology.
[31] J. Quivey,et al. A phase II study of fixed-dose rate gemcitabine plus low-dose cisplatin followed by consolidative chemoradiation for locally advanced pancreatic cancer. , 2007, International journal of radiation oncology, biology, physics.
[32] C. Moertel,et al. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. , 1969, Lancet.
[33] R. Schilsky,et al. Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303). , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[34] R. Wolff,et al. Multi-institutional Phase II Trial of Induction Cetuximab Gemcitabine and Oxaliplatin, followed by R , 2010 .
[35] P. Catalano,et al. Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology Group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] Jeffrey E. Lee,et al. Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] M. Saif,et al. Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer? , 2007, JOP : Journal of the pancreas.
[38] Y. Mataki,et al. Length and quality of survival after external-beam radiotherapy with concurrent continuous 5-fluorouracil infusion for locally unresectable pancreatic cancer. , 2002, International journal of radiation oncology, biology, physics.
[39] Paolo Francescon,et al. Unresectable Locally Advanced Pancreatic Cancer: A Multimodal Treatment Using Neoadjuvant Chemoradiotherapy (Gemcitabine Plus Stereotactic Radiosurgery) and Subsequent Surgical Exploration , 2010, Annals of Surgical Oncology.
[40] H. Ueno,et al. Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer , 2004, British Journal of Cancer.
[41] Wolfgang Schima,et al. Pancreatic adenocarcinoma , 2006, European Radiology.
[42] Quynh-Thu Le,et al. Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. , 2005, International journal of radiation oncology, biology, physics.
[43] T. Desser,et al. Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer. , 2008, International journal of radiation oncology, biology, physics.